JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Simon, G. S.
Right arrow Articles by Dewey, W. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Simon, G. S.
Right arrow Articles by Dewey, W. L.

Narcotics and diabetes. II. Streptozotocin-induced diabetes selectively alters the potency of certain narcotic analgesics. Mechanism of diabetes: morphine interaction

GS Simon, J Borzelleca and WL Dewey

The antinociceptive potencies of phenazocine and levorphanol were altered similarly to that of morphine in streptozotocin (STZ)-induced diabetic and transiently hyper- or hypoglycemic mice, but the potencies of methadone, propoxyphene and meperidine were not altered by changes in serum glucose levels. The acute, s.c. LD50 of morphine in STZ- induced diabetic mice was significantly lower than in the control mice, but the acute s.c. LD50 of methadone was not altered by STZ-induced diabetes. By using morphine as the prototype drug for subsequent experiments, it was demonstrated that the potency of naloxone in antagonizing the effects of morphine in te tail-flick test was not altered in diabetics. Levels of morphine in the brains of STZ-induced diabetic mice were not significantly different from control mice. The durations of action of morphine in STZ-induced diabetes and control mice were similar. We conclude that changes in serum glucose levels can selectively alter the potency of certain narcotic analgesics. The interaction between STZ-induced diabetes and morphine-induced antinociception does not appear to be due to differences in the absorption, distribution or elimination of morphine between diabetic and nondiabetic mice.

Volume 218, Issue 2, pp. 324-329, 08/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
Y. Xing, J. Sonner, M. J. Laster, W. Abaigar, V. B. Caraiscos, B. Orser, and E. I Eger II
Insulin Decreases Isoflurane Minimum Alveolar Anesthetic Concentration in Rats Independently of an Effect on the Spinal Cord
Anesth. Analg., June 1, 2004; 98(6): 1712 - 1717.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
C. Courteix, P. Bourget, F. Caussade, M. Bardin, F. Coudore, J. Fialip, and A. Eschalier
Is the Reduced Efficacy of Morphine in Diabetic Rats Caused by Alterations of Opiate Receptors or of Morphine Pharmacokinetics?
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 63 - 70.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
N. Takeshita and I. Yamaguchi
Insulin Attenuates Formalin-Induced Nociceptive Response in Mice through a Mechanism that Is Deranged by Diabetes Mellitus
J. Pharmacol. Exp. Ther., April 1, 1997; 281(1): 315 - 321.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1981 by the American Society for Pharmacology and Experimental Therapeutics.